rs438931

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_013382.7(POMT2):​c.1786-39C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 1,613,896 control chromosomes in the GnomAD database, including 16,685 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1419 hom., cov: 32)
Exomes 𝑓: 0.14 ( 15266 hom. )

Consequence

POMT2
NM_013382.7 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.517

Publications

10 publications found
Variant links:
Genes affected
POMT2 (HGNC:19743): (protein O-mannosyltransferase 2) The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT1 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS).[provided by RefSeq, Oct 2008]
POMT2 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • myopathy caused by variation in POMT2
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal recessive limb-girdle muscular dystrophy type 2N
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with cerebellar involvement
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 14-77279967-G-A is Benign according to our data. Variant chr14-77279967-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 260297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.313 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POMT2NM_013382.7 linkc.1786-39C>T intron_variant Intron 17 of 20 ENST00000261534.9 NP_037514.2 Q9UKY4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POMT2ENST00000261534.9 linkc.1786-39C>T intron_variant Intron 17 of 20 1 NM_013382.7 ENSP00000261534.4 Q9UKY4-1

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19799
AN:
152028
Hom.:
1416
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.239
Gnomad AMR
AF:
0.153
Gnomad ASJ
AF:
0.164
Gnomad EAS
AF:
0.325
Gnomad SAS
AF:
0.143
Gnomad FIN
AF:
0.0925
Gnomad MID
AF:
0.124
Gnomad NFE
AF:
0.127
Gnomad OTH
AF:
0.141
GnomAD2 exomes
AF:
0.146
AC:
36673
AN:
251062
AF XY:
0.144
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.134
Gnomad ASJ exome
AF:
0.168
Gnomad EAS exome
AF:
0.345
Gnomad FIN exome
AF:
0.0985
Gnomad NFE exome
AF:
0.130
Gnomad OTH exome
AF:
0.138
GnomAD4 exome
AF:
0.138
AC:
202199
AN:
1461750
Hom.:
15266
Cov.:
35
AF XY:
0.138
AC XY:
100253
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.107
AC:
3595
AN:
33480
American (AMR)
AF:
0.142
AC:
6331
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.168
AC:
4382
AN:
26136
East Asian (EAS)
AF:
0.341
AC:
13523
AN:
39686
South Asian (SAS)
AF:
0.142
AC:
12270
AN:
86252
European-Finnish (FIN)
AF:
0.0997
AC:
5322
AN:
53398
Middle Eastern (MID)
AF:
0.129
AC:
743
AN:
5768
European-Non Finnish (NFE)
AF:
0.132
AC:
147244
AN:
1111928
Other (OTH)
AF:
0.146
AC:
8789
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
13134
26267
39401
52534
65668
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5514
11028
16542
22056
27570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.130
AC:
19812
AN:
152146
Hom.:
1419
Cov.:
32
AF XY:
0.131
AC XY:
9774
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.106
AC:
4400
AN:
41504
American (AMR)
AF:
0.152
AC:
2330
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.164
AC:
569
AN:
3472
East Asian (EAS)
AF:
0.326
AC:
1680
AN:
5160
South Asian (SAS)
AF:
0.143
AC:
688
AN:
4826
European-Finnish (FIN)
AF:
0.0925
AC:
979
AN:
10580
Middle Eastern (MID)
AF:
0.130
AC:
38
AN:
292
European-Non Finnish (NFE)
AF:
0.127
AC:
8613
AN:
67984
Other (OTH)
AF:
0.140
AC:
297
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
886
1772
2658
3544
4430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.135
Hom.:
2860
Bravo
AF:
0.135
Asia WGS
AF:
0.199
AC:
694
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.98
DANN
Benign
0.83
PhyloP100
-0.52
PromoterAI
0.018
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs438931; hg19: chr14-77746310; COSMIC: COSV55070239; COSMIC: COSV55070239; API